General description
Etoposide is a plant alkaloid antineoplastic agent, used in treatment protocols for several types of cancer.
INN
Etoposide
ATC codes
Medicine type
Chemical agent
EML status history
First added in 1984
(TRS
722)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2015
(TRS
994)
for
Germ cell tumour of testis
Added in 2015
(TRS
994)
for
Other specified malignant neoplasms of the ovary
Added in 2015
(TRS
994)
for
Other specified malignant neoplasms of bronchus or lung
Added in 2015
(TRS
994)
for
Hodgkin lymphoma
Added in 2015
(TRS
994)
for
Ewing sarcoma of bone and articular cartilage of unspecified sites
Added in 2015
(TRS
994)
for
Retinoblastoma
Added in 2015
(TRS
994)
for
Malignant trophoblastic neoplasms of placenta
Added in 2015
(TRS
994)
for
Burkitt lymphoma including Burkitt leukaemia
Added in 2015
(TRS
994)
for
Lymphoid leukaemia, not elsewhere classified
Removed in 2015
(TRS
994)
for
Unspecified malignant neoplasms of ill-defined or unspecified sites
Added in 2021
(TRS
1035)
for
Myeloid leukaemia
Added in 2021
(TRS
1035)
for
Malignant neoplasms of kidney, except renal pelvis
Added in 2021
(TRS
1035)
for
Osteosarcoma of bone and articular cartilage of unspecified sites
Wikipedia
DrugBank
Recommendations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule
- Oral > Solid: 100 mg capsule
- Oral > Solid: 100 mg capsule; 50 mg capsule
Indications
Unspecified malignant neoplasms of ill-defined or unspecified sites
Germ cell tumour of testis
Malignant trophoblastic neoplasms of placenta
Hodgkin lymphoma
Other specified malignant neoplasms of bronchus or lung
Other specified malignant neoplasms of the ovary
Retinoblastoma
Ewing sarcoma of bone and articular cartilage of unspecified sites
Lymphoid leukaemia, not elsewhere classified
Burkitt lymphoma including Burkitt leukaemia
Myeloid leukaemia
Malignant neoplasms of kidney, except renal pelvis
Osteosarcoma of bone and articular cartilage of unspecified sites